United Therapeutics Corporation Long-term Line of Credit, Noncurrent
United Therapeutics Corporation (UTHR) had Long-term Line of Credit, Noncurrent of $0 as of 2024-12-31, per its 10-K filed 2025-02-26.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LongTermLineOfCredit · last filed 2025-02-26
- 2024-12-31: Long-term Line of Credit, Noncurrent $0.00.
- 2024-09-30: Long-term Line of Credit, Noncurrent $0.00.
- 2024-06-30: Long-term Line of Credit, Noncurrent $100.00M.
- 2024-03-31: Long-term Line of Credit, Noncurrent $200.00M.
| Period end | Long-term Line of Credit, Noncurrent |
|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-02-26 |
| 2024-09-30 | $0.00 10-Q · filed 2024-10-30 |
| 2024-06-30 | $100.00M 10-Q · filed 2024-07-31 |
| 2024-03-31 | $200.00M 10-Q · filed 2024-05-01 |
| 2023-12-31 | $300.00M 10-K · filed 2025-02-26 |
| 2023-09-30 | $500.00M 10-Q · filed 2023-11-01 |
| 2023-06-30 | $800.00M 10-Q · filed 2023-08-02 |
| 2023-03-31 | $800.00M 10-Q · filed 2023-05-03 |
| 2022-12-31 | $800.00M 10-K · filed 2024-02-21 |
| 2022-09-30 | $800.00M 10-Q · filed 2022-11-02 |
| 2022-06-30 | $800.00M 10-Q · filed 2022-08-03 |
| 2022-03-31 | $800.00M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $800.00M 10-K · filed 2023-02-22 |
| 2021-09-30 | $800.00M 10-Q · filed 2021-11-03 |
| 2021-06-30 | $800.00M 10-Q · filed 2021-08-04 |
| 2021-03-31 | $800.00M 10-Q · filed 2021-05-05 |
| 2020-12-31 | $800.00M 10-K · filed 2022-02-24 |
| 2020-09-30 | $800.00M 10-Q · filed 2020-10-28 |
| 2020-06-30 | $800.00M 10-Q · filed 2020-07-29 |
| 2020-03-31 | $800.00M 10-Q · filed 2020-04-29 |
| 2019-12-31 | $600.00M 10-K · filed 2021-02-24 |
| 2019-09-30 | $750.00M 10-Q · filed 2019-10-30 |
| 2019-06-30 | $800.00M 10-Q · filed 2019-07-31 |
| 2019-03-31 | $1.05B 10-Q · filed 2019-05-01 |
| 2018-12-31 | $250.00M 10-K · filed 2020-02-26 |
| 2018-09-30 | $250.00M 10-Q · filed 2018-10-31 |
| 2018-06-30 | $250.00M 10-Q · filed 2018-08-01 |
| 2018-03-31 | $250.00M 10-Q · filed 2018-05-02 |
| 2017-12-31 | $250.00M 10-Q · filed 2018-10-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |